Sonex highlights study on ultrasound-guided carpal tunnel release

Sonex Health is highlighting two-year results showing the safety and efficacy of ultrasound-guided carpal tunnel release (UGCTR) using the UltraGuideCTR device in an office-based setting.

Published in Plastic and Reconstructive Surgery – Global Online, the results from the Robust trial represent the longest and largest prospective evaluation of office-based UGCTR to date, Sonex said.

The prospective, multicenter, observational study enrolled 149 patients and 226 hands across seven U.S. centers, with all procedures performed using only local anesthesia in a clinic setting. More than 92% of patients completed two-year follow-up assessments, according to the researchers.

Key findings at two years include the following:

  • Symptom improvement occurred rapidly within the first two weeks and was sustained through two years.
  • Patients returned to activities and work at two and four days, respectively.
  • Overall satisfaction was 95.7% at the two-year mark, the highest value recorded across the follow-up period.
  • No revisions were required for persistent or recurrent carpal tunnel syndrome symptoms.
  • 52% of patients underwent simultaneous bilateral procedures, which were similarly safe and effective as unilateral procedures.

The study was led by principal investigator Ashley Pistorio, MD, associate professor and plastic surgery residency program director at the University of Nevada, Las Vegas. 

The Robust data add to a body of 21 peer-reviewed publications representing more than 2,200 patients and 2,800 hands supporting UGCTR, Sonex said.

Page 1 of 536
Next Page